Monroe Capital LLC announced it acted as sole lead arranger and administrative agent on the funding of a $30 million senior credit facility to support the growth of a diagnostic services company.
 
Based in the Southwest, the company provides specialized toxicology and pathology diagnostic lab testing services to clinical healthcare providers in the nature of urine drug monitoring for pain management, addiction medicine, and other outpatient screening/compliance monitoring providers, and standardized gastrointestinal and dermatological lab testing services.
 
This transaction is representative of Monroe Capital’s extensive capabilities in its healthcare vertical.

Monroe Capital LLC is a leading provider of senior and junior debt and equity co-investments to middle-market companies in the U.S. and Canada. Investment types include unitranche financings, cash flow and enterprise value based loans, acquisition facilities, mezzanine debt, second lien or last-out loans and equity co-investments. Monroe Capital prides itself on its flexible investment approach and its ability to close and fund transactions quickly. Monroe is committed to being a value-added and user-friendly partner to owners, senior management and private equity sponsors.